CEOs to Offer Perspectives on Economic Future of Advanced Biofuels and Renewable Chemicals at World Congress

WASHINGTON, D.C. (Monday, March 09, 2009) - The worldwide financial crisis could impact the ability of industrial biotechnology companies to obtain financing for new projects to produce advanced biofuels and biobased products. The Biotechnology Industry Organization (BIO) announced today that CEOs of biobased product, biofuel and industrial biotechnology companies will offer their views on how the industry might survive the business downturn at the 2009 World Congress on Industrial Biotechnology and Bioprocessing, to be held July 19-22, 2009 in Montreal, Quebec, Canada.

Brent Erickson, executive vice president of BIO’s Industrial and Environmental Section, said, “Clean-tech and green product companies are particularly vulnerable in the current financing crisis, even though their growth and development offer opportunities for sustainable industrial production, new green jobs, and future economic growth. Executives from companies on the cutting-edge of the industry will meet in July at BIO’s World Congress on Industrial Biotechnology and Bioprocessing to share perspectives on the ability of the industry to achieve future growth. The World Congress has grown into the premier event for leaders from the biotechnology and bioprocessing industries, academia, and science community.”

The opening plenary session, “How Can Industrial Biotechnology Thrive in the Global Economic Crisis?,” will be held on Mon. July 20. Featured speakers include:

·         Christopher Gann, CEO, Genomatica, USA;

·         Stephen Gatto, Chairman and CEO, BioEnergy International, LLC, USA;

·         K’Lynne Johnson, CEO, Elevance Renewable Sciences, USA;

·         Jens Riese, Principal, Biofuels and Industrial Biotech Practice, McKinsey & Co., USA;

·         Alan Shaw, CEO, Codexis, USA; and

·         Marc Verbruggen, President and CEO, NatureWorks LLC, USA.


The closing plenary session, “The Future of the Biofuels Value Chain,” will be held Wed. July 22. Featured speakers include:

·         Ross MacLachlan, CEO, Lignol, Canada;

·         Carlos Riva, CEO, Verenium, USA; and

·         Johnathan Wolfson, CEO, Solazyme, USA.


The annual World Congress on Industrial Biotechnology and Bioprocessing is the original and only conference dedicated solely to industrial biotechnology and the most recent advancements in the field. Now in its sixth year, the conference will move to its largest venue to date, the Palais des congrès de Montréal (the Montreal Convention Centre). The conference web site is

All programs at the World Congress on Industrial Biotechnology and Bioprocessing are open to attendance by members of the media. Registration for the World Congress is complimentary for credentialed members of the news media. Reporters and editors working full-time for print, broadcast, and online news organizations may register onsite with valid media credentials. All freelancers, college and online publications are strongly encouraged to register in advance. For more information, please visit

The Advanced Biofuels & Climate Change Information Center presents the latest commentary and data on the environmental, greenhouse gas and other impacts of biofuel production. Drop in and add your comments, at

Upcoming BIO Events

BIO-Europe Spring
March 16-18, 2009
Milan, Italy

BIO IP Counsels' Committee Conference
March 25–27, 2009
Phoenix, AZ

BIO National Venture Conference
March 31–April 1,2009
Boston, MA

BIO Windhover 2009
April 13-15, 2009
New York, NY

BIO-LES Business Development Basics Course
May 15–17, 2009
Atlanta, GA  

BIO-LES Advanced Business Development Course
May 15–17, 2009
Atlanta, GA 

BIO Executive Presentation Workshop
May 17, 2009
Atlanta, GA

BIO Human Resources Conference
May 17-19, 2009
Atlanta, GA

2009 BIO International Convention
May 18-21, 2009
Atlanta, Ga.

BioEquity Europe
June 9-10, 2009
Munich, Germany

World Congress on Industrial Biotechnology & Bioprocessing
July 19-22, 2009
Montreal, Quebec, Canada


About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.